Cooperative Interaction Within RNA Virus Mutant Spectra

Author(s):  
Yuta Shirogane ◽  
Shumpei Watanabe ◽  
Yusuke Yanagi
Author(s):  
Akeeb O .bola Oyefolu ◽  
Joseph Ojonugwa Shaibu ◽  
Abdul-azeez A. Anjorin ◽  
Kabiru O. Akinyemi

Background: Zika virus, a flavivirus primarily transmitted through bites of mosquito (Aedes aegypti), blood transfusion, sexual contact and motherto-child was named after Zika forest in Uganda where it was first isolated from a sentinel monkey in 1947. It is a positively sensed single stranded RNA virus (+ssRNA) of approximately 11000Kb in length, encoding three (3) structural and seven (7) non-structural proteins. The virus has spread across several countries of the world between 1947 and today. Between March 2015 and November 2016, about 500,000 to 1.5 million people have been reported infected with Zika virus in Brazil alone, resulting in several cases of microcephaly, severe brain and ocular malformations, abortions, Guillain-Barre syndrome and even deaths. Cases of Zika virus infections have also been documented in some African countries with resulting isolation and sequencing of several strains. In Nigeria however, the first case of Zika virus was reported as far back as 1954 in the Eastern part of the country during a research on Yellow fever. Zika virus mutant strains might have evolved with corresponding effects on man due to continuous environmental changes and human factors worldwide. Aim: This study was aimed at reviewing the state of Zika virus in Nigeria: past and present. Methods: Original research articles and reviews were searched on the NCBI, Research gate, PubMed and Google scholar using queries such as; Zika, epidemiology of Zika, pathogenesis of Zika and molecular characterization of Zika. Results: High points on virology, epidemiology, pathogenesis, diagnosis, prevention and management were pooled together and discussed. Conclusion: The knowledge gained from this paper will help understand the current state of Zika virus in Nigeria. Keywords: Nigeria, Zika, flavivirus, RNA, microcephaly, epidemiology, genomics.


Author(s):  
N. H. Olson ◽  
T. S. Baker ◽  
Wu Bo Mu ◽  
J. E. Johnson ◽  
D. A. Hendry

Nudaurelia capensis β virus (NβV) is an RNA virus of the South African Pine Emperor moth, Nudaurelia cytherea capensis (Lepidoptera: Saturniidae). The NβV capsid is a T = 4 icosahedron that contains 60T = 240 subunits of the coat protein (Mr = 61,000). A three-dimensional reconstruction of the NβV capsid was previously computed from visions embedded in negative stain suspended over holes in a carbon film. We have re-examined the three-dimensional structure of NβV, using cryo-microscopy to examine the native, unstained structure of the virion and to provide a initial phasing model for high-resolution x-ray crystallographic studiesNβV was purified and prepared for cryo-microscopy as described. Micrographs were recorded ∼1 - 2 μm underfocus at a magnification of 49,000X with a total electron dose of about 1800 e-/nm2.


Author(s):  
Parth Sarthi Sen Gupta ◽  
Satyaranjan Biswal ◽  
Saroj Kumar Panda ◽  
Abhik Kumar Ray ◽  
Malay Kumar Rana

<p>While an FDA approved drug Ivermectin was reported to dramatically reduce the cell line of SARS-CoV-2 by ~5000 folds within 48 hours, the precise mechanism of action and the COVID-19 molecular target involved in interaction with this in-vitro effective drug are unknown yet. Among 12 different COVID-19 targets studied here, the RNA dependent RNA polymerase (RdRp) with RNA and Helicase NCB site show the strongest affinity to Ivermectin amounting -10.4 kcal/mol and -9.6 kcal/mol, respectively. Molecular dynamics of corresponding protein-drug complexes reveals that the drug bound state of RdRp with RNA has better structural stability than the Helicase NCB site, with MM/PBSA free energy of -135.2 kJ/mol, almost twice that of Helicase (-76.6 kJ/mol). The selectivity of Ivermectin to RdRp is triggered by a cooperative interaction of RNA-RdRp by ternary complex formation. Identification of the target and its interaction profile with Ivermectin can lead to more powerful drug designs for COVID-19 and experimental exploration. </p>


Sign in / Sign up

Export Citation Format

Share Document